Completed OBSERVATIONAL NCT00001733

Screening for Studies on Retinovascular Diseases

Screening Study for the Evaluation and Diagnosis of Potential Research Subjects With Retinovascular Diseases

Sponsor: National Eye Institute (NEI)

Conditions Diabetic Retinopathy Macular Degeneration Pathologic Neovascularization Retinal Disease

Updated 6 times since 2017 Last updated: Jun 30, 2017 Started: Mar 6, 1998 Completion: Jul 2, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00001733, this observational or N/A phase trial focuses on Diabetic Retinopathy and Macular Degeneration and remains completed. Sponsored by National Eye Institute (NEI), it has been updated 6 times since 1998, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Mar 1998

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Eye Institute (NEI)

Data source: National Institutes of Health Clinical Center (CC)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bethesda, United States